文献速递生殖医学妇科

月经周期时相与BMI对PMOS子宫内膜线粒体功能障碍的影响

The impact of menstrual cycle phase and BMI on mitochondrial dysfunction in PMOS endometrium.
PubMed 文献 · Hum Reprod · 2026-01-01

本研究对78名排卵稀发女性(PMOS组39例、对照组39例,年龄和BMI匹配)在四个月经周期时相取子宫内膜行RNA测序,并体外培养子宫内膜间质细胞和上皮类器官进行功能验证。发现PMOS子宫内膜转录组紊乱具有周期时相特异性且主要与线粒体功能相关;肥胖PMOS者蜕膜化间质细胞线粒体呼吸降低,而瘦型PMOS者上皮类器官线粒体活性增加。

要点

  • PMOS子宫内膜转录组紊乱呈周期时相特异性,以线粒体功能相关改变最突出。
  • 肥胖PMOS者蜕膜化间质细胞线粒体呼吸降低,瘦型PMOS者上皮类器官线粒体活性增加。
  • 着床窗口期线粒体功能障碍可能是PMOS子宫内膜异常的关键病理特征。

核心结论

  • 排卵稀发PMOS女性子宫内膜存在周期时相特异性转录组紊乱,线粒体功能障碍尤其在着床窗口期是核心病理特征。

研究设计与样本

  • 对78名(稀发)排卵女性(PMOS组39例、对照组39例,年龄和BMI匹配)四个周期时相的子宫内膜活检行RNA测序。
  • 体外实验使用另一子宫内膜样本队列来源的培养子宫内膜间质细胞和上皮类器官,每个BMI组各4例PMOS和4例对照供者。

主要发现

  • 子宫内膜转录组主要按周期时相聚类,但PMOS特异性紊乱涉及细胞外基质组织、雌激素受体信号、离子转运和线粒体呼吸功能。
  • 基因轨迹分析显示早分泌期孕酮、胰岛素信号和线粒体相关基因表达以及中分泌期上皮功能存在时相特异性改变。
  • 肥胖PMOS女性蜕膜化间质细胞线粒体呼吸降低,而瘦型PMOS患者上皮类器官线粒体活性增加。

关键数值与推荐

  • 体外功能实验按BMI分组:瘦型为<25 kg/m2,肥胖为≥30 kg/m2。
  • 线粒体功能评估指标包括呼吸、ATP和活性氧产生以及膜电位,在激素暴露前后于两种细胞类型中检测。

临床怎么用

  • 对排卵稀发PMOS女性应关注子宫内膜线粒体功能,尤其着床窗口期,作为潜在干预靶点。
  • 线粒体功能改变呈BMI依赖性差异,提示需按BMI制定个体化治疗策略以改善生殖结局。

局限性

  • PMOS组为排卵稀发而对照组为规律周期,两组排卵状态不一致。
  • 体外研究样本量较小,需更大队列验证。
  • 采用bulk RNA测序可能掩盖细胞类型特异性转录组特征,需未来单细胞方法解析细胞异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Does the endometrium of oligo-ovulatory women with polyendocrine metabolic ovarian syndrome (PMOS) exhibit menstrual cycle phase-specific transcriptomic alterations compared to women without PMOS? SUMMARY ANSWER: Compared to healthy controls, women with PMOS exhibit endometrial transcriptomic dysregulations which are menstrual cycle phase-specific and, most notably, related to mitochondrial function. WHAT IS KNOWN ALREADY: Infertility and gestational dysfunction in women with PMOS are increasingly attributed to endometrial abnormalities, yet the underlying mechanisms behind PMOS-related endometrial dysfunction remain unclear. Previous studies have focused on anovulatory phenotypes, resulting in a poor understanding of cycle phase-specific defects in the endometria of women with PMOS. STUDY DESIGN, SIZE, DURATION: Endometrial biopsies were obtained from oligo-ovulatory women with PMOS and healthy controls at four distinct menstrual cycle phases (proliferative, early-, mid-, and late-secretory phases) and subjected to RNA sequencing. Parallel in vitro experiments were conducted using cultured endometrial stromal cells (ESCs) and epithelial organoids (EEOs) derived from an additional endometrial sample cohort. PARTICIPANTS/MATERIALS, SETTING, METHODS: RNA sequencing was performed on biopsies from 78 (oligo-)ovulatory women, age- and BMI-matched between PMOS (n = 39) and control (n = 39) groups. Phase-specific transcriptomic profiles and pathway enrichment analyses were performed. For functional assays, endometrial cells were isolated from four PMOS and four control donors per BMI group (lean: < 25 kg/m2; obese: ≥30 kg/m2). Mitochondrial function, including respiration, ATP and reactive oxygen species production, and membrane potential, was assessed in both cell types before and after hormonal exposure. MAIN RESULTS AND THE ROLE OF CHANCE: Endometrial transcriptomes clustered primarily by cycle phase; however, PMOS-specific dysregulation was observed related to extracellular matrix organization, estrogen receptor (ESR) signaling, ion transport, and mitochondrial respiratory function. Gene trajectory analyses revealed phase-specific alterations in progesterone-, insulin signaling-, and mitochondria-related gene expression during the early-secretory phase, and epithelial function during the mid-secretory phase. Functionally, decidualized ESCs from obese PMOS women displayed reduced mitochondrial respiration, whereas EEOs from lean PMOS patients exhibited increased mitochondrial activity. LARGE SCALE DATA: Sequencing data are available from the corresponding author upon request. LIMITATIONS, REASONS FOR CAUTION: Women with PMOS were oligo-ovulatory while controls exhibited regular cycles. The sample size for in vitro studies was modest, warranting validation in larger cohorts. Additionally, the use of bulk RNA sequencing may obscure cell-type-specific transcriptomic signatures, emphasizing the need for future single-cell approaches to dissect cellular heterogeneity in PMOS endometrium. WIDER IMPLICATIONS OF THE FINDINGS: This study uncovers dynamic, cycle phase-dependent molecular and bioenergetic alterations in the endometrium of oligo-ovulatory women with PMOS. Mitochondrial dysfunction, particularly during the implantation window, emerges as a key pathological feature. The observed BMI-dependent divergence in mitochondrial function suggests that personalized therapeutic strategies may be necessary to improve reproductive outcomes in women with PMOS. FUNDING: Funded by the Jusélius Foundation, Novo Nordisk Foundation, Research Council of Finland, and the Horizon 2020 Marie-Curie MATER Innovative Training Network (all to T.T.P.), with additional support from the University of Oulu Scholarship Foundation (L.L.), the Estonian Research Council (E.V.M. and I.R.), and the Estonian Research Council grant no. PRG1076, Swedish Research Council grant no. 2024-02530, Novo Nordisk Foundation grant no. NNF24OC0092384 and Horizon Europe grant NESTOR, grant no. 101120075 (A.S.). DISCLOSURES: The authors declare no competing interests.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Luyckx L, Myllykangas M, Kinnunen J, et al. The impact of menstrual cycle phase and BMI on mitochondrial dysfunction in PMOS endometrium. Hum Reprod. 2026. PMID: 42575864. doi:10.1093/humrep/deag127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。